Skip to main content
Cancer Immunology, Immunotherapy : CII logoLink to Cancer Immunology, Immunotherapy : CII
. 1991 Jan;33(1):39–44. doi: 10.1007/BF01742526

Macrophage-activating factor extracted from mycoplasmas

Morio Takema 1,2, Shogo Oka 2, Kazuko Uno 1,3, Shinji Nakamura 1, Hitoshi Arita 2, Katsuya Tawara 2, Kayo Inaba 1, Shigeru Muramatsu 1,
PMCID: PMC11038429  PMID: 1902396

Abstract

Mycoplasmas (M. gallisepticum, chicken mycoplasmas), in concert with interferon γ (IFNγ), were effective in activating macrophages (Mθ) to be tumoricidal. The Mθ-activating capacity of mycoplasmas was maintained after treatment with heat, 0.1 M NaOH, 1 M HC1, or trypsin. Mθ-activating factor was extracted from mycoplasmas with chloroform/methanol and water (Mf-B). Mf-B was also effective in activating Mθ in the presence of IFNγ. The threshold dose of Mf-B for Mθ of ordinary C3H/He mice and that for those of C3H/HeJ mice, the latter being known to be low responders to bacterial lipopolysaccharide, were actually the same. This seems to indicate that the effectiveness of Mf-B was not attributable to possibly contaminating lipopolysaccharides, and that the pathway of activity of Mf-B is different from that of lipopolysaccharides. Since the Mθ-activating principle was only a very small part of Mf-B, we have not yet succeeded in identifying it, but there was no evidence that it was protein, nucleic acid, sugar, or lipid. The cytotoxicity of Mθ activated by Mf-B plus IFNγ was dependent onl-arginine in the culture, suggesting that arginine metabolites are involved in Mθ cytotoxicity. Mf-B induced a small amount of tumor necrosis factor in Mθ, and this induction was markedly enhanced by IFNγ.

Keywords: Lipid, Sugar, Nucleic Acid, Cancer Research, Tumor Necrosis

References

  • 1.Alexander P, Evans R. Endotoxin and double stranded RNA render macrophages cytotoxic. Nat New Biol. 1971;232:76. doi: 10.1038/newbio232076a0. [DOI] [PubMed] [Google Scholar]
  • 2.Atkin CL, Cole BC, Sullivan GJ, Washburn LR, Wiley BB. Stimulation of mouse lymphocytes by a mitogen derived from Mycoplasma arthritidis. V. A small basic protein from culture supernatants is a potent T cell mitogen. J Immunol. 1986;137:1581. [PubMed] [Google Scholar]
  • 3.Bekoff MC, Cole BC, Grey HM. Studies on the mechanisms of stimulation of T cells by the Mycoplasma arthritidis-derived mitogen. Role of class II IE molecules. J Immunol. 1987;139:3189. [PubMed] [Google Scholar]
  • 4.Beutler B, Tkacenko V, Milsark I, Krochin N, Cerami A. Effect of γ interferon on cachectin expression by mononuclear phagocytes. Reversal of the lpsd (endotoxin resistance) phenotype. J Exp Med. 1986;164:1791. doi: 10.1084/jem.164.5.1791. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol. 1959;37:911. doi: 10.1139/o59-099. [DOI] [PubMed] [Google Scholar]
  • 6.Boraschi D, Meltzer MS. Defective tumoricidal capacity of macrophages from A/J mice: II. Comparison of the macrophage cytotoxic defect of A/J mice with that of lipid A-unresponsive C3H/HeJ mice. J Immunol. 1979;122:1592. [PubMed] [Google Scholar]
  • 7.Gallily R, Sher T, Ben-Av P, Loewenstein J. Tumor necrosis factor as a mediator of Mycoplasma orale-induced tumor cell lysis by macrophages. Cell Immunol. 1989;121:146. doi: 10.1016/0008-8749(89)90012-9. [DOI] [PubMed] [Google Scholar]
  • 8.Hibbs JB, Jr, Taintor RR, Vavrin Z. Macrophage cytotoxicity: role forl-arginine deiminase and imino nitrogen oxidation to nitrite. Science. 1987;235:473. doi: 10.1126/science.2432665. [DOI] [PubMed] [Google Scholar]
  • 9.Hibbs JB, Jr, Vavrin Z, Taintor RR. l-Arginine is required for expression of the activated macrophage effector mechanism causing selective metabolic inhibition in target cells. J Immunol. 1987;138:550. [PubMed] [Google Scholar]
  • 10.Matthes M, Schrezenmeier H, Homfeld J, Fleischer S, Malissen B, Kirchner H, Fleischer B. Clonal analysis of human T cell activation by the Mycoplasma arthritidis mitogen (MAS) Eur J Immunol. 1988;18:1733. doi: 10.1002/eji.1830181112. [DOI] [PubMed] [Google Scholar]
  • 11.Nakano K, Abe S, Sohmura Y. Recombinant tumor necrosis factor. I. Cytotoxic activity in vitro. Int J Immunopharmacol. 1986;8:347. doi: 10.1016/0192-0561(86)90117-7. [DOI] [PubMed] [Google Scholar]
  • 12.Proust JJ, Buchholz MA, Nordin AA. A “lymphokine-like” soluble product that induces proliferation and maturation of B cells appears in the serum-free supernatant of a T cell hybridoma as a consequence of mycoplasmal contamination. J Immunol. 1985;134:390. [PubMed] [Google Scholar]
  • 13.Ruco LP, Meltzer MS. Defective tumoricidal capacity of macrophages from C3H/HeJ mice. J Immunol. 1978;120:329. [PubMed] [Google Scholar]
  • 14.Ruuth E, Lundgren E. Enhancement of immunoglobulin secretion by the lymphokine-like activity of a Mycoplasma arginini strain. Scand J Immunol. 1986;23:575. doi: 10.1111/j.1365-3083.1986.tb01990.x. [DOI] [PubMed] [Google Scholar]
  • 15.Sher T, Rottem S, Gallily R. Mycoplasma capricolum membranes induce tumor necrosis factor α by a mechanism different from that of lipopolysaccharide. Cancer Immunol Immunother. 1990;31:86. doi: 10.1007/BF01742371. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Smith PF, Langworthy TA, Mayberry WR. Distribution and composition of lipopolysaccharides from mycoplasmas. J Bacteriol. 1976;125:916. doi: 10.1128/jb.125.3.916-922.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Stuehr DJ, Nathan CF. Nitric oxide. A macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. J Exp Med. 1989;169:1543. doi: 10.1084/jem.169.5.1543. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Uno K, Takema M, Hidaka S, Tanaka R, Konishi T, Kato T, Nakamura S, Muramatsu S (1990) Induction of antitumor activity in macrophages by mycoplasmas in concert with interferon. Cancer Immunol Immunother (in press) [DOI] [PMC free article] [PubMed]
  • 19.Westphal O, Luderitz O, Bister F. Uber die Extraktion von Bakterien mit Phenol-Wasser. Z Naturforsch. 1952;7B:148. [Google Scholar]

Articles from Cancer Immunology, Immunotherapy : CII are provided here courtesy of Springer

RESOURCES